U.S. federal trademark · Serial No. 99182363
gene therapy products, namely, genetically modified cells for medical use for the treatment of dystrophic epidermolysis bullosa; pharmaceutical preparations and injectable biological preparations containing genetically modified materials for treatment of dystrophic epidermolysis bullosa; pharmaceutical preparations and therapeutic preparations for treatment of skin diseases, connective tissue diseases, arthritis and autoimmune diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.